BLS sees potential FY27 ‘upside’ as UK facility nears launch by Adam Sheldon September 8, 2026September 9, 2026 BLS Pharmaceuticals has flagged a potential increase to its FY27 revenue guidance, revealing its forecast of […]
Alternaleaf fastest-growing UK brand by search visibility by Adam Sheldon August 6, 2026August 6, 2026
Creditor claims in the multi millions as Cannim sale process continues by Adam Sheldon November 13, 2025November 17, 2025
Rua launches NZ$2m capital raise in bid to reach ‘self-sustaining position’ by Adam Sheldon November 4, 2025February 21, 2026
LGP explores more deals after Health House purchase and ‘applauds’ possible crackdown by regulators by Steve Jones February 12, 2025February 13, 2025
